The role of neuromodulation in the management of urinary urge incontinence

BJU International

Volumn 91, Issue 4, 2003, Pages 355-359

  Abrams, P ^a   Blaivas, J G ^g   Fowler, C J ^b   Fourcroy, J L ^c   MacDiarmid, S A ^d   Siegel, S W ^e   Van Kerrebroeck, P ^f  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e Metropolitan Urologic Specialists   (United States)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g NONE

Author keywords

Neuromodulation; Neurourology; Outcome; Urinary urge incontinence

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; NERVE STIMULATION; NEUROMODULATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SPINAL ROOT; TREATMENT OUTCOME; URGE INCONTINENCE; URINE FLOW RATE; URINE INCONTINENCE; URODYNAMICS;

ADOLESCENT; ADULT; AGED; COSTS AND COST ANALYSIS; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 0037351340     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04105.x     Document Type: Article

References (22)

1. Wyman JF, Harkins SW, Choi SC et al. Psychosocial impact of urinary incontinence in women. Obset Gynecol 1987; 70: 378-81
2. Diokno AC, Brock BM, Brown D. Prevalence of urinary incontinence and other urological symptoms in non-institutionalised patients. J Urol 1986; 136: 1022-5
3. Johnson MJ, Werner C. We had no choice. A study of familial guilt feelings surrounding nursing home care. J Gerentol Nurs 1982; 8: 641-5
4. Wagner TH, Wu TW. Economic costs of urinary incontinence in 1995. Urology 1998; 51: 355-61
5. Andersson KE, Appell R, Cardozo L et al. Pharmacological treatment of urinary incontinence. In Abrams P, Khoury S, Wein A eds, Incontinence. Plymouth: Health Publication Ltd, 1999: 447-86
6. Yarker YE, Goa KL, Fitton A. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Ageing 1995; 6: 243-62
7. Appell R, Sand D, Dmochowski R et al. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder. Results of the OBJECT Study. Mayo Clin Proc 2001; 76: 358-63
8. Van Kerrebroeck P, Kreder K, Jonas U et al. Tolterodine once-daily: superior efficacy and tolerability in the treatment of overactive bladder. Urology 2001; 57: 414-21
9. Newgreen DT, Anderson CWP, Carter AJ, Naylor AM. Darifenacin - a novel bladder-selective agent for the treatment of urge incontinence. Neurourol Urodyn 1995; 14: 95-6
10. Fall M, Lindstrom S. Electrical stimulation. A physiologic approach to the treatment or urinary incontinence. Urol Clin North Am 1991; 18: 393
11. Schmidt RA, Senn E, Tanagho EA. Functional evaluation of sacral root integrity. Report of a technique. Urology 1990; 35: 388-92
12. Lindstrom S, Fall M, Carlsson CA, Erlandson BE. The neurophysiological basis of bladder inhibition in response to intravaginal electrical stimulation. J Urol 1983; 129: 405-10
13. Schmidt RA, Jonas U, Oleson KA. Sacral nerve stimulation for the treatment of refractory urge incontinence. J Urol 1999; 162: 352-7
14. Hassouna MM, Siegel SW, Lycklama a Nijeholt AAB et al. Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicentre study on efficacy and safety. J Urol 2000; 163: 1849-54
15. Jonas U, Fowler CJ, Grunewald V. Efficacy of sacral nerve stimulation for urinary retention: results up to 18 months after implantation. J Urol 2001; 165: 15-9
16. Shaker S, Hassouna MM. Sacral nerve root modulation: an effective treatment for refractory urinary urge incontinence. J Urol 1998; 159: 1516-9
17. Weil EH, Ruiz-Cerda JL, Eerdmans PH et al. Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomised trial. Eur Urol 2000; 37: 161-72
18. Wagner TH, Patrick DL, Bavendam TG et al. Quality of life of persons with urinary incontinence: development of a new measure. Urology 2000; 47: 67-72
19. Bosch R, Groen J. Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability, results of chronic electrical stimulation using an implantable neural prosthesis. J Urol 1995; 154: 504-7
20. Grunewald V, Hofner K, Thon WF et al. Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunction. Restor Neurol Neuosci 1999; 14: 189-93
21. Janknegt RA, Weil E, Erdmans P. improving neuromodulation technique for refractory voiding dysfunctions: two stage implant. Urology 1997; 49: 358-62
22. Spinelli M, Mamo GA, Ardini A et al. Evolution of minimally-invasive procedure for sacral neuromodulation. In Jonas U, Grunewald V eds, New Perspectives in Sacral Nerve Stimulation. London: Martin Dunitz Ltd, 2002: 217-22